Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. is a dynamic biopharmaceutical company committed to the development, manufacturing, and commercialization of groundbreaking inflammation and immunology (I&I) biological products. Scinai Immunotherapeutics Ltd. focuses primarily on treatments for autoimmune and infectious diseases. Located at Jerusalem BioPark, Hadassah Ein Kerem Campus, Jerusalem, Jerusalem 00000, IL, Scinai Immunotherapeutics Ltd. leverages a state-of-the-art facility and the expertise of seasoned pharmaceutical industry leaders to provide comprehensive, boutique CDMO services.

In addition to its CDMO offerings, Scinai Immunotherapeutics Ltd. is actively developing a diversified pipeline of commercially viable products and platforms, spearheading innovation with its nanosized VHH antibody (NanoAb) pipeline. These NanoAbs are targeted towards diseases with significant unmet medical needs, highlighting Scinai's commitment to addressing critical healthcare challenges and improving patient outcomes.

Scinai Immunotherapeutics Ltd. is dedicated to advancing the future of biopharmaceutical solutions. We invite the management team at Scinai Immunotherapeutics Ltd. to enhance your company's presence on our platform by creating a customized and exclusive company showcase and product listing. This will further highlight the exceptional work being done at Scinai Immunotherapeutics Ltd.